1
Clinical Trials associated with TAVO103AA Phase 1, Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAVO103A in Adult Healthy Subjects
This is a Phase 1, single ascending dose study designed to investigate TAVO103A, administered as an IV infusion up to 60 minutes in length to healthy adult subjects. This study is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAVO103A.
100 Clinical Results associated with TAVO103A
100 Translational Medicine associated with TAVO103A
100 Patents (Medical) associated with TAVO103A
100 Deals associated with TAVO103A